These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4543801)

  • 1. Vanilmandelic acid urinary excretion in the diagnosis of retinoblastoma.
    Renelt P; Trieschmann W
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1973 Nov; 188(4):281-3. PubMed ID: 4543801
    [No Abstract]   [Full Text] [Related]  

  • 2. Excretion of vanilmandelic acid in the urine of retinoblastoma patients.
    François J; Koliopoulos J
    Ophthalmologica; 1979; 178(4):181-5. PubMed ID: 481863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary vanilmandelic acid (VMA) levels in children with retinoblastoma].
    Szreterowa M; Kornacki B; Chrzanowska K
    Klin Oczna; 1982 Sep; 84(9):289-90. PubMed ID: 6891732
    [No Abstract]   [Full Text] [Related]  

  • 4. Normal urinary excretion of catecholamine catabolites in children with retinoblastoma.
    Orlowski JP; Levin HS; Price RL; Dyment PG
    Med Pediatr Oncol; 1978; 4(4):343-9. PubMed ID: 723798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of vanilmandelic acid in urine in retinoblastoma].
    Artiko GH; Litricin O; Milenković S
    Srp Arh Celok Lek; 1981 Aug; 109(8):1031-8. PubMed ID: 7345634
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between urinary excretion of vanilmandelic acid (VMA) and clinical progress in 15 cases of neuroblastoma].
    Takada H; Inui A; Imashuku S; Kusunoki T; Sawada A
    Nihon Shonika Gakkai Zasshi; 1971 Oct; 75(10):917-23. PubMed ID: 5169739
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy].
    Lamedica G; Falcone R; De Bernardi B; Canini S
    Minerva Pediatr; 1978 Jan; 30(2):137-46. PubMed ID: 642879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Excretion of vanilmandelic acid in 2 cases of retinoblastoma].
    Frezzotti R; Guerra R; Bonanni R
    Boll Ocul; 1967 Oct; 46(10):765-71. PubMed ID: 5605853
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.
    LaBrosse EH; Com-Nougué C; Zucker JM; Comoy E; Bohuon C; Lemerle J; Schweisguth O
    Cancer Res; 1980 Jun; 40(6):1995-2001. PubMed ID: 7371035
    [No Abstract]   [Full Text] [Related]  

  • 10. [The importance of the determination of urinary catecholamines and urinary vanilmandelic acid in the diagnosis and control of neuroblastoma therapy].
    Rutiloni C; Serra GB
    Minerva Pediatr; 1968 Dec; 20(48):2481-7. PubMed ID: 5715834
    [No Abstract]   [Full Text] [Related]  

  • 11. Stage and urinary catecholamine metabolite excretion in neuroblastoma. European Neuroblastoma Study Group.
    Pritchard J; Barnes J; Germond S; Hartman O; de Kraker J; Lewis I; Lockwood L; Wallendszus K
    Lancet; 1989 Aug; 2(8661):514-5. PubMed ID: 2570230
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary levels of vanilmandelic acid and homovanillic acid determined by high-speed liquid chromatography.
    Yoshida A; Yoshioka M; Yamazaki T; Sakai T; Tamura Z
    Clin Chim Acta; 1976 Dec; 73(2):315-20. PubMed ID: 1000851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion of octopamine metabolites in neuroblastoma.
    Couch MW; Greer DM; Williams CM
    Clin Chim Acta; 1986 Jul; 158(1):109-14. PubMed ID: 3091293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of HMMA in children.
    Walters EG; Proctor DG; Elder GH; Walters G
    Ann Clin Biochem; 1989 Jan; 26 ( Pt 1)():44-8. PubMed ID: 2735747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the diurnal variations in urinary homovanillic and vanillylmandelic acid excretion for the diagnosis and follow-up of patients with neuroblastoma.
    Tuchman M; Robison LL; Maynard RC; Ramnaraine ML; Krivit W
    Clin Biochem; 1985 Jun; 18(3):176-9. PubMed ID: 4039636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystathioninuria in patients with neuroblastoma or ganglioneuroblastoma. Its correlation to vanilmandelic acid excretion and its value in diagnosis and therapy.
    Geiser CF; Efron ML
    Cancer; 1968 Oct; 22(4):856-60. PubMed ID: 5212308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary cystathionine, catecholamine, and metabolites in patients with neuroblastoma.
    Helson L; Fleisher M; Bethune V; Murphy ML; Schwartz MK
    Clin Chem; 1972 Jul; 18(7):613-5. PubMed ID: 5037905
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of urinary VMA determination in the neuroblastoma].
    Hanawa Y; Ise Y; Murakami T; Sakauchi N; Nagato T
    Nihon Shonika Gakkai Zasshi; 1970 Feb; 74(2):252-9. PubMed ID: 5461857
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of catecholamine excretion in the follow-up of sympathoblastomas.
    Barontini de Gutiérrez ; Bergadá C; Becú L
    Cancer; 1971 Jan; 27(1):228-32. PubMed ID: 4321900
    [No Abstract]   [Full Text] [Related]  

  • 20. 4-hydroxy-3-methoxymandelic acid (HMMA) excretion in retinoblastoma.
    Dias PL; Amarasiri AA
    Br J Ophthalmol; 1978 Aug; 62(8):525-7. PubMed ID: 687548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.